A61K 2039/6037
Bacterial toxins
Official title: {Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]}
A61K2039/6037 (Bacterial toxins) appears on 948 US grants and 1,440 published applications in this corpus.
Search patents in A61K- Granted patents
- 948
- Published applications
- 1,440
- Assignees
- 557
- Inventors
- 2,173
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 14 | 0 |
| 1998 | 17 | 0 |
| 1999 | 20 | 0 |
| 2000 | 16 | 0 |
| 2001 | 14 | 5 |
| 2002 | 11 | 26 |
| 2003 | 19 | 32 |
| 2004 | 24 | 41 |
| 2005 | 18 | 58 |
| 2006 | 12 | 48 |
| 2007 | 9 | 32 |
| 2008 | 9 | 43 |
| 2009 | 14 | 64 |
| 2010 | 23 | 58 |
| 2011 | 20 | 55 |
| 2012 | 23 | 44 |
| 2013 | 30 | 50 |
| 2014 | 55 | 55 |
| 2015 | 42 | 73 |
| 2016 | 52 | 65 |
| 2017 | 44 | 55 |
| 2018 | 60 | 73 |
| 2019 | 47 | 60 |
| 2020 | 60 | 79 |
| 2021 | 51 | 80 |
| 2022 | 42 | 75 |
| 2023 | 33 | 87 |
| 2024 | 54 | 79 |
| 2025 | 47 | 53 |
| 2026 | 23 | 50 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F15 Sep 2026US 12,734,229 B2Inventprise, LLC
- Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines11 Aug 2026US 12,702,705 B2Glaxosmithkline Biologicals SA
- Pegylated tetanus neurotoxins and treatment of hypotonia4 Aug 2026US 12,697,379 B2Snoretox Pty Ltd
- Immunogenic composition comprising multivalent Streptococcus pneumoniae polysaccharide-protein conjugates14 Jul 2026US 12,678,494 B2Celltrion Inc.
- Method for improving immunogenicity of protein/peptide antigen7 Jul 2026US 12,673,102 B2SinoCellTech Ltd.
- Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof24 Sep 2026US 2026/0284170 A1Pfizer Inc.
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Vaccines targeting pseudomonas aeruginosa10 Sep 2026US 2026/0265312 A1Evaxion Biotech A/S
- Treatment of atopic dermatitis using self-replicating rna expressing il-3120 Aug 2026US 2026/0240967 A1Ceva Sante Animale
- Immunogenic Composition20 Aug 2026US 2026/0240990 A1Glaxosmithkline Biologicals SA
Most cited
By later US patents
- Immunogenic polysaccharide-protein conjugates208US 4,356,170 ACanadian Patents and Development Limited · 1982
- Prevention and treatment of amyloidogenic disease160US 6,743,427 B1Neuralab Limited · 2004
- Immunogenic conjugates154US 4,673,574 A1987
- Submicron emulsions as vaccine adjuvants129US 5,961,970 APharmos Corporation · 1999
- Humanized and chimeric N-terminal amyloid beta-antibodies109US 6,750,324 B1Neuralab Limited · 2004